Stay updated on Tavo in Melanoma Post-Checkpoint Inhibitors Clinical Trial
Sign up to get notified when there's something new on the Tavo in Melanoma Post-Checkpoint Inhibitors Clinical Trial page.

Latest updates to the Tavo in Melanoma Post-Checkpoint Inhibitors Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe location entry for Italy was updated from Napoli, Italy, 80131 to Naples, Italy, 80131.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a system-wide update and does not affect study details.SummaryDifference0.0%

- Check26 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check47 days agoChange DetectedThe new screenshot shows only minor UI/layout adjustments with no changes to essential study information such as eligibility criteria, enrollment, or primary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check54 days agoChange DetectedThe site update introduces Revision: v3.4.2, replacing the previous Revision: v3.4.1. This change is limited to versioning and does not affect the study content, eligibility criteria, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check61 days agoChange DetectedAdded a government funding notice about potential delays and updated the site’s operating status. The site revision was updated to v3.4.1 and the previous v3.4.0 revision was removed.SummaryDifference0.3%

Stay in the know with updates to Tavo in Melanoma Post-Checkpoint Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tavo in Melanoma Post-Checkpoint Inhibitors Clinical Trial page.